British hospitals are testing a game-changing “personalised” type of radiotherapy that erases the disease in double-quick time and boosts survival chances.It is hoped the treatment could be available on the NHS within two years.
Prostate cancer is the most common form of the disease in men accounting for 25 per cent of all cases. It kills 11,000 in Britain every year. But the milestone treatment offers fresh hope to 40,000 men newly diagnosed every year. Express.
